Cargando…

Cytogenetically-based biodosimetry after high doses of radiation

Dosimetry is an important tool for triage and treatment planning following any radiation exposure accident, and biological dosimetry, which estimates exposure dose using a biological parameter, is a practical means of determining the specific dose an individual receives. The cytokinesis-blocked micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujol-Canadell, Monica, Perrier, Jay R., Cunha, Lidia, Shuryak, Igor, Harken, Andrew, Garty, Guy, Brenner, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176141/
https://www.ncbi.nlm.nih.gov/pubmed/32320391
http://dx.doi.org/10.1371/journal.pone.0228350
_version_ 1783524961743273984
author Pujol-Canadell, Monica
Perrier, Jay R.
Cunha, Lidia
Shuryak, Igor
Harken, Andrew
Garty, Guy
Brenner, David J.
author_facet Pujol-Canadell, Monica
Perrier, Jay R.
Cunha, Lidia
Shuryak, Igor
Harken, Andrew
Garty, Guy
Brenner, David J.
author_sort Pujol-Canadell, Monica
collection PubMed
description Dosimetry is an important tool for triage and treatment planning following any radiation exposure accident, and biological dosimetry, which estimates exposure dose using a biological parameter, is a practical means of determining the specific dose an individual receives. The cytokinesis-blocked micronucleus assay (CBMN) is an established biodosimetric tool to measure chromosomal damage in mitogen-stimulated human lymphocytes. The CBMN method is especially valuable for biodosimetry in triage situations thanks to simplicity in scoring and adaptability to high-throughput automated sample processing systems. While this technique produces dose-response data which fit very well to a linear-quadratic model for exposures to low linear energy transfer (LET) radiation and for doses up for 5 Gy, limitations to the accuracy of this method arise at larger doses. Accuracy at higher doses is limited by the number of cells reaching mitosis. Whereas it would be expected that the yield of micronuclei increases with the dose, in many experiments it has been shown to actually decrease when normalized over the total number of cells. This variation from a monotonically increasing dose response poses a limitation for retrospective dose reconstruction. In this study we modified the standard CBMN assay to increase its accuracy following exposures to higher doses of photons or a mixed neutron–photon beam. The assay is modified either through inhibitions of the G2/M and spindle checkpoints with the addition of caffeine and/or ZM447439 (an Aurora kinase inhibitor), respectively to the blood cultures at select times during the assay. Our results showed that caffeine addition improved assay performance for photon up to 10 Gy. This was achieved by extending the assay time from the typical 70 h to just 74 h. Compared to micronuclei yields without inhibitors, addition of caffeine and ZM447439 resulted in improved accuracy in the detection of micronuclei yields up to 10 Gy from photons and 4 Gy of mixed neutrons-photons. When the dose-effect curves were fitted to take into account the turnover phenomenon observed at higher doses, best fitting was achieved when the combination of both inhibitors was used. These techniques permit reliable dose reconstruction after high doses of radiation with a method that can be adapted to high-throughput automated sample processing systems.
format Online
Article
Text
id pubmed-7176141
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71761412020-05-12 Cytogenetically-based biodosimetry after high doses of radiation Pujol-Canadell, Monica Perrier, Jay R. Cunha, Lidia Shuryak, Igor Harken, Andrew Garty, Guy Brenner, David J. PLoS One Research Article Dosimetry is an important tool for triage and treatment planning following any radiation exposure accident, and biological dosimetry, which estimates exposure dose using a biological parameter, is a practical means of determining the specific dose an individual receives. The cytokinesis-blocked micronucleus assay (CBMN) is an established biodosimetric tool to measure chromosomal damage in mitogen-stimulated human lymphocytes. The CBMN method is especially valuable for biodosimetry in triage situations thanks to simplicity in scoring and adaptability to high-throughput automated sample processing systems. While this technique produces dose-response data which fit very well to a linear-quadratic model for exposures to low linear energy transfer (LET) radiation and for doses up for 5 Gy, limitations to the accuracy of this method arise at larger doses. Accuracy at higher doses is limited by the number of cells reaching mitosis. Whereas it would be expected that the yield of micronuclei increases with the dose, in many experiments it has been shown to actually decrease when normalized over the total number of cells. This variation from a monotonically increasing dose response poses a limitation for retrospective dose reconstruction. In this study we modified the standard CBMN assay to increase its accuracy following exposures to higher doses of photons or a mixed neutron–photon beam. The assay is modified either through inhibitions of the G2/M and spindle checkpoints with the addition of caffeine and/or ZM447439 (an Aurora kinase inhibitor), respectively to the blood cultures at select times during the assay. Our results showed that caffeine addition improved assay performance for photon up to 10 Gy. This was achieved by extending the assay time from the typical 70 h to just 74 h. Compared to micronuclei yields without inhibitors, addition of caffeine and ZM447439 resulted in improved accuracy in the detection of micronuclei yields up to 10 Gy from photons and 4 Gy of mixed neutrons-photons. When the dose-effect curves were fitted to take into account the turnover phenomenon observed at higher doses, best fitting was achieved when the combination of both inhibitors was used. These techniques permit reliable dose reconstruction after high doses of radiation with a method that can be adapted to high-throughput automated sample processing systems. Public Library of Science 2020-04-22 /pmc/articles/PMC7176141/ /pubmed/32320391 http://dx.doi.org/10.1371/journal.pone.0228350 Text en © 2020 Pujol-Canadell et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pujol-Canadell, Monica
Perrier, Jay R.
Cunha, Lidia
Shuryak, Igor
Harken, Andrew
Garty, Guy
Brenner, David J.
Cytogenetically-based biodosimetry after high doses of radiation
title Cytogenetically-based biodosimetry after high doses of radiation
title_full Cytogenetically-based biodosimetry after high doses of radiation
title_fullStr Cytogenetically-based biodosimetry after high doses of radiation
title_full_unstemmed Cytogenetically-based biodosimetry after high doses of radiation
title_short Cytogenetically-based biodosimetry after high doses of radiation
title_sort cytogenetically-based biodosimetry after high doses of radiation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176141/
https://www.ncbi.nlm.nih.gov/pubmed/32320391
http://dx.doi.org/10.1371/journal.pone.0228350
work_keys_str_mv AT pujolcanadellmonica cytogeneticallybasedbiodosimetryafterhighdosesofradiation
AT perrierjayr cytogeneticallybasedbiodosimetryafterhighdosesofradiation
AT cunhalidia cytogeneticallybasedbiodosimetryafterhighdosesofradiation
AT shuryakigor cytogeneticallybasedbiodosimetryafterhighdosesofradiation
AT harkenandrew cytogeneticallybasedbiodosimetryafterhighdosesofradiation
AT gartyguy cytogeneticallybasedbiodosimetryafterhighdosesofradiation
AT brennerdavidj cytogeneticallybasedbiodosimetryafterhighdosesofradiation